Lung Cancer News From Medical News TodayLatest Lung Cancer News From Medical News Today.Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine Or Vinorelbine In Performance Status (PS 2) NSCLC Patients- July 7, 2008 Cell Therapeutics, Inc. (CTI) announced the publication of results from its randomized phase III trial comparing OPAXIO(TM) (paclitaxel poliglumex, CT-2103) with gemcitabine or vinorelbine for the treatment of PS 2 (performance status 2) patients with previously untreated non-small cell lung cancer (NSCLC) in the Journal of Thoracic Oncology (Volume 3, Number 7, July 2008). Results showed that overall survival was similar between the two arms (hazard ratio of 0.http://www.medicalnewstoday.com/articles/114104.php A Report By Leading Clinical Researchers On The Current Quantitative Imaging Tools For Lung Cancer Drug Assessment- July 4, 2008 Research and Markets has announced the addition of the "Quantitative Imaging Tools for Lung Cancer Drug Assessment" report to their offering.http://www.medicalnewstoday.com/articles/113958.php Circulating Tumor Cells Can Reveal Genetic Signature Of Dangerous Lung Cancers- July 3, 2008 Massachusetts General Hospital (MGH) investigators have shown that an MGH-developed, microchip-based device that detects and analyzes tumor cells in the bloodstream can be used to determine the genetic signature of lung tumors, allowing identification of those appropriate for targeted treatment and monitoring genetic changes that occur during therapy.http://www.medicalnewstoday.com/articles/113846.php Linking Second-Hand Smoke And Lung Cancer- July 3, 2008 It is a widely accepted notion that second-hand smoke (SHS) is linked to lung cancer. However, medical professionals and researchers have not reached consensus on the extent of the increase in cancer risk due to SHS.http://www.medicalnewstoday.com/articles/113713.php Smokeless Tobacco Can Also Increase Cancer Risk- July 3, 2008 A review published in The Lancet Oncology finds that although users of smokeless tobacco products (STPs) likely have a lower cancer risk than smokers, they are still increasing their risk of developing several types of cancer. In the USA and Sweden, a finely cut or powered, flavored tobacco called moist snuff is the most popular form of STP used. In places like India, there is a wide range of products that are regularly consumed.http://www.medicalnewstoday.com/articles/113500.php Smoke-Free Policies Are Achieving Intended Goals- July 2, 2008 A new article published in The Lancet Oncology claims that the recent smoke-free policy initiatives have resulted in numerous public health gains. The special report from the International Agency for Cancer Research (IARC) reveals that the policies have been instrumental in reducing heart disease related to smoke exposure, diminishing the number of adults who smoke, and curbing second-hand smoke exposure to adults and children.http://www.medicalnewstoday.com/articles/113489.php Percutaneous Radiofrequency Ablation Shows Promise In The Treatment Of Lung Tumours- July 1, 2008 Percutaneous radiofrequency ablation - a minimally invasive treatment technique that heats and destroys cancer cells - achieves a high rate of sustained complete responses in selected patients with lung tumours, according to results from the first prospective study of patients treated with technique. Tumours in the lungs are common. Lung cancer is the leading cause of cancer death in both men and women.http://www.medicalnewstoday.com/articles/113425.php Peregrine Pharmaceuticals Doses First Patient In Phase II Trial Of Bavituximab In Patients With Non-Small Cell Lung Cancer- July 1, 2008 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) announced that patient screening and dosing has begun in a Phase II trial designed to evaluate the safety and efficacy of bavituximab in combination with chemotherapy in patients with non-small cell lung cancer (NSCLC). The primary objective of the study is to assess the overall response rate to the combination of bavituximab with a standard regimen of carboplatin and paclitaxel in NSCLC patients.http://www.medicalnewstoday.com/articles/113359.php |